Correlation Between Ideaya Biosciences and Compass Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ideaya Biosciences and Compass Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ideaya Biosciences and Compass Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ideaya Biosciences and Compass Therapeutics, you can compare the effects of market volatilities on Ideaya Biosciences and Compass Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ideaya Biosciences with a short position of Compass Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ideaya Biosciences and Compass Therapeutics.
Diversification Opportunities for Ideaya Biosciences and Compass Therapeutics
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ideaya and Compass is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and Compass Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Therapeutics and Ideaya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ideaya Biosciences are associated (or correlated) with Compass Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Therapeutics has no effect on the direction of Ideaya Biosciences i.e., Ideaya Biosciences and Compass Therapeutics go up and down completely randomly.
Pair Corralation between Ideaya Biosciences and Compass Therapeutics
Given the investment horizon of 90 days Ideaya Biosciences is expected to generate 1.53 times less return on investment than Compass Therapeutics. But when comparing it to its historical volatility, Ideaya Biosciences is 1.77 times less risky than Compass Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Compass Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 211.00 in Compass Therapeutics on May 27, 2025 and sell it today you would earn a total of 91.00 from holding Compass Therapeutics or generate 43.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ideaya Biosciences vs. Compass Therapeutics
Performance |
| Timeline |
| Ideaya Biosciences |
| Compass Therapeutics |
Ideaya Biosciences and Compass Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ideaya Biosciences and Compass Therapeutics
The main advantage of trading using opposite Ideaya Biosciences and Compass Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ideaya Biosciences position performs unexpectedly, Compass Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Therapeutics will offset losses from the drop in Compass Therapeutics' long position.| Ideaya Biosciences vs. Crinetics Pharmaceuticals | Ideaya Biosciences vs. Viridian Therapeutics | Ideaya Biosciences vs. Cytokinetics | Ideaya Biosciences vs. Structure Therapeutics American |
| Compass Therapeutics vs. Annexon | Compass Therapeutics vs. Centessa Pharmaceuticals PLC | Compass Therapeutics vs. Crinetics Pharmaceuticals | Compass Therapeutics vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |